Search
Enter keywords, a title or a report id number below.
Your Search for 'Cancer Diagnostics: Early Detection of Breast, Prostate and Colorectal Cancer' returned 26 results - Page 1 of 2
Sort by
Sorted by
Rank
Top-Bottom
-
Biomarkers - Technologies, Markets and Companies
Jain PharmaBiotech, May 2013 , Pages: 920Role of bioinformatics in detection of cancer biomarkers Biomarker databases Gene networks as biomarkers Role of bioinformatics in integrating various data and biomarker discovery Evaluation of ... -
Molecular Diagnostics - Technologies, Markets and Companies
Jain PharmaBiotech, May 2013 , Pages: 1090Prostate cancer Early detection of prostate cancer recurrence by nanotechnology Gene expression analysis of prostate cancer Huntingtin Interacting Protein 1 Integrative genomic and proteomic profiling of ... -
Personalized Medicine - Scientific and Commercial Aspects
Jain PharmaBiotech, May 2013 , Pages: 854Personlized management of prostate cancer Diagnostics for guiding therapy of prostate cancer Prolaris assay for determining prognosis in prostate cancer Detection of prostate cancer metastases Early ... -
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
TriMark Publications, Sep 2011 , Pages: 343morbidity in a disease this complex is early detection and diagnosis. In the major solid cancer types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has ... -
Neogenix Oncology, Inc. - Product Pipeline Analysis
GlobalData, Nov 2012 , Pages: 52products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. The company is uniquely ... -
Analysis of the U.S. Cancer Biomarker Testing Market
Frost & Sullivan, Jul 2012 , Pages: 105treatment. -Although patient forecasts were not used to generate the revenue forecast, new annual patient forecasts for breast, prostate, lung, colorectal, and other cancer sites* are included for reference ... -
MDxHealth SA (MDXH) - Product Pipeline Analysis
GlobalData, Nov 2012 , Pages: 84advanced molecular diagnostic tests for early cancer detection and personalized treatment decisions. It focuses mainly on three different types of cancers, namely, prostate cancer, colorectal cancer and lung ... -
Biomoda, Inc. (BMOD) - Product Pipeline Analysis
GlobalData, Nov 2012 , Pages: 68Biomoda, Inc. (BMOD) - Product Pipeline Analysis Summary Biomoda, Inc. (Biomoda) is a cancer diagnostics company, based in the US. It develops and manufactures in-vitro test for the early detection ... -
MabCure Inc. (MBCI) - Product Pipeline Analysis
GlobalData, Nov 2012 , Pages: 25markets. It develops novel molecular antibodies as diagnostic tools for the detection of prostate and ovarian cancers at an early stage. The company also develops new technologies for the early detection of ... -
MDxHealth SA (ONCOB) - Product Pipeline Analysis
GlobalData, Nov 2011 , Pages: 40treatment products, molecular cancer diagnostics, personalized treatment solutions which are used in the diagnosis of various cancers including prostate cancer, colorectal cancer, bladder cancer, breast ... -
Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics
GBI Research, Dec 2010 , Pages: 1243.1.3 Patient compliance 3.1.4 Early detection of disease 3.1.5 Better regulatory norms and validation procedures encourage growth of the personalized medicine market 3.2 Barriers 3.2.1 Payer ... -
Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
GlobalData, May 2011 , Pages: 135numerous opportunities for determining genetic predisposition, the early detection of tumors, and monitoring biological responses to cancer therapy. This report is built using data and information sourced ... -
The Top 100 Molecular Diagnostics Manufacturing Companies Worldwide
Research Facts Ltd, Mar 2009The Top 100 Molecular Diagnostics Manufacturing Companies Worldwide Molecular diagnostics enables the early detection of diseases and conditions, the selection of targeted, individualised treatment ... -
Innovations in Diagnostics: Next Generation Molecular and Point-of-Care Diagnostics Driving Personalized Healthcare
Scripp Business Insights, Sep 2006 , Pages: 126Breast cancer Colorectal cancer Leukemia Lung cancer Prostate cancer Future challenges Chapter 6 Point-of-care testing Summary Introduction Blood glucose tests Case study: Scout test for diabetes ... -
Biomarkers - Global Strategic Business Report
Global Industry Analysts, Inc, Aug 2011 , Pages: 1305development of diagnostics and therapeutics targeting cancer. The technology’s capabilities to increase productivity by detecting the most appropriate drug candidate in the early R&D process offers significant ... -
GeneNews Limited (GEN) - Product Pipeline Analysis
GlobalData, Nov 2012 , Pages: 29tests for early disease detection. It develops diagnostic tests such as, ColonSentry and SentinelGx. GeneNews ColonSentry is a blood test for colorectal cancer and SentinelGx is used in whole blood ... -
Targeted Cancer Therapies: Innovative Drugs And Their Impact On The Future Of Oncology
Scripp Business Insights, Aug 2004 , Pages: 155diagnosis of cancer? - What are the unmet needs in cancer treatment? - What new treatments are being developed in areas such as breast cancer, colorectal cancer and prostate cancer? - Who are the key players ... -
Emerging Medical Technologies Spotlight
Life Science Intelligence, May 2013molecular diagnostics that track multiple biomarkers for early diagnosis of a variety of diseases including cancer and Alzheimer's - Company 114 - Magnetically targeted drug delivery system enabling patient ... -
Cancer Biomarkers: New Tools for Transforming Cancer Management
Decision Resources, Inc, Apr 2007 , Pages: 34- Trends in Cancer Biomarker Development: Biomarker discovery and validation, as well as the role of the diagnostics. - Emerging Biomarkers in Select Cancers: Bladder, breast, colorectal, lung, pancreatic ... -
Biomarkers Market Discovery Technologies (Proteomics, Genomics, Imaging, Bioinformatics), Applications (Drug Discovery, Personalized Medicine, Molecular Diagnostics) & Indications (Cancer, Cardiovascular & Neural) Global Trends & Forecasts (2011 – 20
Markets and Markets, Feb 2012 , Pages: 542and on their usage in decision making in early drug development. With drug development facing challenges from ever increasing cost of developing drugs and rise in the failure rate for drugs in phase II ...
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
